Novoxel Inc. announces the U.S. FDA clearance of the Tixel i (pronounced “Tixel Eye”) for sale in the USA.

Simple Relief™ from Dry Eye comes from 2-minute treatment with Tixel i®

SIMPLE RELIEF: Gregg J. Berdy M.D., F.A.C.S., an ophthalmologist in St. Louis, Missouri, said, “I was part of the clinical study, so I was excited to purchase the first Tixel i because my patients reported significant relief of their symptoms. Unlike other systems, the procedure is simple: anesthesia is not required, no coupling gel is needed, there are no complicated applicators, and there are no bright flashes of light. And, the Tixel i is simple and safe enough for my staff to perform the procedures. The upper and lower eyelids of both eyes can be treated in less than 2 minutes. Most patients say their eyes feel more watery during the actual treatment.”

CONTINUED INNOVATION: “In June of this year, Novoxel Inc. introduced our new Tixel 2 system for aesthetic procedures. Just a short while later, we are excited to launch another member of the Tixel family,” said Lee Pannell, CEO of Novoxel Inc. “The Tixel i treatment regimen is very short: only three treatments, spaced two weeks apart. What impressed me the most is that after the treatments are finished, the scores continued to improve. And the improvement is sustained for at least six months.”

Sign up for Blog Updates